PL377696A1 - Enancjomery pochodnych kwasu tiofenohydroksamowego i ich zastosowanie jako inhibitorów HDAC - Google Patents
Enancjomery pochodnych kwasu tiofenohydroksamowego i ich zastosowanie jako inhibitorów HDACInfo
- Publication number
- PL377696A1 PL377696A1 PL377696A PL37769603A PL377696A1 PL 377696 A1 PL377696 A1 PL 377696A1 PL 377696 A PL377696 A PL 377696A PL 37769603 A PL37769603 A PL 37769603A PL 377696 A1 PL377696 A1 PL 377696A1
- Authority
- PL
- Poland
- Prior art keywords
- enantiomers
- acid derivatives
- hydroxamic acid
- hdac inhibitors
- thiophene hydroxamic
- Prior art date
Links
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 title 1
- 239000003276 histone deacetylase inhibitor Substances 0.000 title 1
- XNSXTZGRPNUMTQ-UHFFFAOYSA-N n-hydroxythiophene-2-carboxamide Chemical class ONC(=O)C1=CC=CS1 XNSXTZGRPNUMTQ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02028038 | 2002-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL377696A1 true PL377696A1 (pl) | 2006-02-06 |
Family
ID=32524005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377696A PL377696A1 (pl) | 2002-12-16 | 2003-12-15 | Enancjomery pochodnych kwasu tiofenohydroksamowego i ich zastosowanie jako inhibitorów HDAC |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7098241B2 (pl) |
| EP (1) | EP1575933A1 (pl) |
| JP (1) | JP2006513181A (pl) |
| KR (1) | KR100781929B1 (pl) |
| CN (1) | CN100391954C (pl) |
| AR (1) | AR042459A1 (pl) |
| AU (1) | AU2003293882A1 (pl) |
| BR (1) | BR0317348A (pl) |
| CA (1) | CA2507629A1 (pl) |
| CL (1) | CL2003002611A1 (pl) |
| GT (1) | GT200300285A (pl) |
| PA (1) | PA8592101A1 (pl) |
| PE (1) | PE20040913A1 (pl) |
| PL (1) | PL377696A1 (pl) |
| RU (1) | RU2348625C2 (pl) |
| TW (1) | TW200418825A (pl) |
| UY (1) | UY28127A1 (pl) |
| WO (1) | WO2004054999A1 (pl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2363396A1 (en) * | 2001-06-11 | 2011-09-07 | Virochem Pharma Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| DE60332482D1 (de) | 2002-12-10 | 2010-06-17 | Virochem Pharma Inc | Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen |
| US7375228B2 (en) | 2003-03-17 | 2008-05-20 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
| US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
| CN1964962A (zh) * | 2004-06-14 | 2007-05-16 | 霍夫曼-拉罗奇有限公司 | 噻吩异羟肟酸衍生物以及它们作为hdac抑制剂的应用 |
| CN1980920A (zh) * | 2004-06-14 | 2007-06-13 | 霍夫曼-拉罗奇有限公司 | 噻吩衍生物、它们的制备以及作为药剂的应用 |
| JP2008502627A (ja) * | 2004-06-14 | 2008-01-31 | エフ.ホフマン−ラ ロシュ アーゲー | ヒドロキサム酸塩、その製造、および薬剤としての使用 |
| US7642275B2 (en) | 2004-12-16 | 2010-01-05 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| JP2008540574A (ja) | 2005-05-11 | 2008-11-20 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
| JP5030947B2 (ja) * | 2005-05-13 | 2012-09-19 | ヴァイロケム・ファーマ・インコーポレーテッド | フラビウイルス感染の治療及び予防のための化合物及び方法 |
| CA2615105A1 (en) | 2005-07-14 | 2007-01-25 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| GB0518237D0 (en) * | 2005-09-07 | 2005-10-19 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| GB0522130D0 (en) * | 2005-10-31 | 2005-12-07 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| GB0603041D0 (en) * | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| SG176488A1 (en) * | 2006-11-15 | 2011-12-29 | Virochem Pharma Inc | Thiophene analogues for the treatment or prevention of flavivirus infections |
| AR074797A1 (es) | 2008-10-10 | 2011-02-16 | Japan Tobacco Inc | Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial |
| WO2011106627A1 (en) * | 2010-02-26 | 2011-09-01 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| WO2011106632A1 (en) * | 2010-02-26 | 2011-09-01 | Millennium Pharmaceuticals, Inc. | Substituted hydroxamic acids and uses thereof |
| WO2012019772A1 (en) * | 2010-08-12 | 2012-02-16 | Institut De Recherche Pour Le Developpement (I.R.D) | Method for treating protozoan parasitic diseases |
| WO2012112447A2 (en) * | 2011-02-14 | 2012-08-23 | Dana-Farber Cancer Institute, Inc. | Histone deacetylase inhibitors and methods of use thereof |
| WO2013052110A1 (en) | 2011-10-03 | 2013-04-11 | The Trustees Of Columbia University In The City Of New York | Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1 |
| TWI633885B (zh) | 2013-03-15 | 2018-09-01 | 日商日本煙草產業股份有限公司 | 吡唑-醯胺化合物及其醫藥用途 |
| CN103159646B (zh) * | 2013-03-19 | 2014-10-22 | 广东药学院 | 一种异羟肟酸类化合物及其制备方法和应用 |
| CA2933907A1 (en) | 2013-12-23 | 2015-07-02 | The Trustees Of Columbia University In The City Of New York | Selective hdac6 inhibitors |
| TWI773657B (zh) | 2015-12-18 | 2022-08-11 | 美商亞德利克斯公司 | 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物 |
| US12084472B2 (en) | 2015-12-18 | 2024-09-10 | Ardelyx, Inc. | Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists |
| EP3492452B1 (en) | 2016-07-29 | 2022-08-31 | Japan Tobacco Inc. | Production method for pyrazole-amide compound |
| CN116120300B (zh) * | 2023-02-21 | 2024-10-15 | 贵州大学 | 一种含异羟肟酸片段的嘧啶类化合物其制备方法和应用 |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL6406688A (pl) * | 1964-06-05 | 1965-12-06 | ||
| BE661226A (fr) | 1965-03-17 | 1965-09-17 | Acides arylacethydroxamiques, amides correspondants et procedes de preparation. | |
| GB1200886A (en) * | 1966-09-23 | 1970-08-05 | Allen & Hanburys Ltd | Phenylaminoethanol derivatives |
| US4173652A (en) * | 1976-12-18 | 1979-11-06 | Akzona Incorporated | Pharmaceutical hydroxamic acid compositions and uses thereof |
| NL7614113A (nl) | 1976-12-18 | 1978-06-20 | Akzo Nv | Hydroxamzuren. |
| JPS5436229A (en) | 1977-08-25 | 1979-03-16 | Hokuriku Pharmaceutical | Substituted acetohydroxam derivative |
| JPS57145838A (en) | 1981-03-05 | 1982-09-09 | Hodogaya Chem Co Ltd | P-benzyloxybenzoic acid derivative and herbicide containing the same |
| JPS57149254A (en) | 1981-03-10 | 1982-09-14 | Hodogaya Chem Co Ltd | M-benzyloxybenzamide derivative and herbicide containing the same |
| GB8320702D0 (en) | 1983-08-01 | 1983-09-01 | Wellcome Found | Chemotherapeutic agents |
| US4769461A (en) * | 1986-09-16 | 1988-09-06 | American Home Products Corporation | Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents |
| GB8728051D0 (en) | 1987-12-01 | 1988-01-06 | Leo Pharm Prod Ltd | Chemical compounds |
| JPH01216961A (ja) | 1988-02-25 | 1989-08-30 | Takeda Chem Ind Ltd | 12−リポキシゲネース阻害剤 |
| DE3903989A1 (de) | 1989-02-10 | 1990-09-20 | Basf Ag | Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika |
| US5091533A (en) | 1990-03-12 | 1992-02-25 | Merck Frosst Canada, Inc. | 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors |
| JPH04217950A (ja) | 1990-03-28 | 1992-08-07 | Asahi Chem Ind Co Ltd | ヒドロキサム酸誘導体および酵素阻害剤ならびに抗潰瘍剤 |
| JPH03291264A (ja) | 1990-04-06 | 1991-12-20 | Japan Tobacco Inc | ジメチルアニリン誘導体、その製造方法及びそれを有効成分として含有するガン細胞分化誘導検査試薬及び制癌剤 |
| JPH04187666A (ja) | 1990-11-20 | 1992-07-06 | Asahi Chem Ind Co Ltd | シクロヘキサンカルボン酸アミド誘導体及び酵素阻害剤ならびに抗潰瘍剤 |
| US5700811A (en) * | 1991-10-04 | 1997-12-23 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and method of use thereof |
| US5369108A (en) * | 1991-10-04 | 1994-11-29 | Sloan-Kettering Institute For Cancer Research | Potent inducers of terminal differentiation and methods of use thereof |
| EP0544166A3 (en) * | 1991-11-26 | 1993-11-03 | Hoffmann La Roche | Cephalosporinderivatives |
| ES2124790T3 (es) | 1992-07-16 | 1999-02-16 | Dow Chemical Co | Copolicarbonatos de tiodifenol y su uso como componentes de cuerpos reflectantes polimericos multicapa. |
| US5783593A (en) | 1993-11-04 | 1998-07-21 | Abbott Laboratories | Inhibitors of squalene synthetase and protein farnesyltransferase |
| US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| US6008257A (en) * | 1994-01-28 | 1999-12-28 | Bayer Aktiengesellschaft | Hydroxamic-acid derivatives, method of preparing them and their use as fungicides |
| GB9420557D0 (en) | 1994-10-12 | 1994-11-30 | Zeneca Ltd | Aromatic compounds |
| EP0820441B1 (en) | 1995-04-10 | 2002-06-26 | Fujisawa Pharmaceutical Co., Ltd. | INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| ATE212632T1 (de) | 1995-09-08 | 2002-02-15 | Univ Princeton | Nicht-klassische antifolate |
| AU7392696A (en) | 1995-10-04 | 1997-04-28 | Warner-Lambert Company | Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins |
| FR2746098B1 (fr) | 1996-03-14 | 1998-04-30 | Composes propynyl biaromatiques | |
| AUPO118896A0 (en) | 1996-07-23 | 1996-08-15 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| CA2262682A1 (en) | 1996-08-05 | 1998-02-12 | Prolinx, Inc. | Boronic compound complexing reagents and highly stable complexes |
| US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
| JPH10114654A (ja) | 1996-10-09 | 1998-05-06 | Fujisawa Pharmaceut Co Ltd | 新規用途 |
| AU743901B2 (en) | 1996-10-16 | 2002-02-07 | Wyeth Holdings Corporation | Ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloprote inase and tace inhibitors |
| US6392010B1 (en) * | 1996-12-19 | 2002-05-21 | Aventis Pharmaceuticals Inc. | Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and αβ-unsaturated carboxylic acid and aldehyde compounds |
| JPH10182583A (ja) | 1996-12-25 | 1998-07-07 | Mitsui Chem Inc | 新規ヒドロキサム酸誘導体 |
| PT960096E (pt) | 1997-01-22 | 2005-08-31 | Aventis Pharma Inc | Acidos beta-tiocarboxilicos substituidos |
| AU748998B2 (en) | 1997-02-27 | 2002-06-13 | Wyeth Holdings Corporation | N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| US6696449B2 (en) | 1997-03-04 | 2004-02-24 | Pharmacia Corporation | Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| JPH10259176A (ja) | 1997-03-17 | 1998-09-29 | Japan Tobacco Inc | 血管新生阻害作用を有する新規アミド誘導体及びその用途 |
| JPH10287634A (ja) | 1997-04-11 | 1998-10-27 | Otsuka Pharmaceut Co Ltd | ベンゼン誘導体 |
| WO1998057945A1 (en) | 1997-06-17 | 1998-12-23 | Schering Corporation | Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| AU749132B2 (en) | 1997-08-28 | 2002-06-20 | Biovitrum Ab | Inhibitors of protein tyrosine phosphatase |
| AU8998398A (en) | 1997-09-09 | 1999-03-29 | Shionogi & Co., Ltd. | 4-substituted benzoic acid derivatives and carcinostatics containing the same asthe active ingredient |
| CN1138760C (zh) | 1997-10-06 | 2004-02-18 | 惠氏控股公司 | 作为基质金属蛋白酶和tace抑制剂的邻亚磺酰氨基二环杂芳基异羟肟酸的制备和用途 |
| PT1025077E (pt) | 1997-10-15 | 2007-05-31 | Wyeth Corp | Novas ariloxi-alquil-dialquilaminas |
| CN1213021C (zh) | 1998-02-19 | 2005-08-03 | 惠氏控股公司 | 作为基质金属蛋白酶抑制剂的 n -羟基- 2 - (烷基、芳基或杂芳基硫烷基、亚磺酰基或磺酰基 ) - 3 -取代的烷 |
| EP0960882A1 (en) * | 1998-05-19 | 1999-12-01 | Hoechst Marion Roussel Deutschland GmbH | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| KR20100035666A (ko) * | 1999-11-23 | 2010-04-05 | 메틸진 인크. | 히스톤 디아세틸라제의 억제제 |
| JP2003528074A (ja) | 2000-03-24 | 2003-09-24 | メチルジーン インコーポレイテッド | ヒストン脱アセチル化酵素の阻害剤 |
| US6784173B2 (en) * | 2001-06-15 | 2004-08-31 | Hoffmann-La Roche Inc. | Aromatic dicarboxylic acid derivatives |
| WO2003055479A1 (en) * | 2001-12-21 | 2003-07-10 | Consejo Superior De Investigaciones Cientificas | Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3 |
-
2003
- 2003-12-10 US US10/732,633 patent/US7098241B2/en not_active Expired - Fee Related
- 2003-12-10 TW TW092134881A patent/TW200418825A/zh unknown
- 2003-12-11 PA PA20038592101A patent/PA8592101A1/es unknown
- 2003-12-11 PE PE2003001262A patent/PE20040913A1/es not_active Application Discontinuation
- 2003-12-12 AR ARP030104605A patent/AR042459A1/es unknown
- 2003-12-12 CL CL200302611A patent/CL2003002611A1/es unknown
- 2003-12-12 GT GT200300285A patent/GT200300285A/es unknown
- 2003-12-15 UY UY28127A patent/UY28127A1/es not_active Application Discontinuation
- 2003-12-15 CN CNB2003801059568A patent/CN100391954C/zh not_active Expired - Fee Related
- 2003-12-15 WO PCT/EP2003/014235 patent/WO2004054999A1/en not_active Ceased
- 2003-12-15 AU AU2003293882A patent/AU2003293882A1/en not_active Abandoned
- 2003-12-15 KR KR1020057011170A patent/KR100781929B1/ko not_active Expired - Fee Related
- 2003-12-15 RU RU2005122447/04A patent/RU2348625C2/ru not_active IP Right Cessation
- 2003-12-15 JP JP2004560408A patent/JP2006513181A/ja not_active Ceased
- 2003-12-15 PL PL377696A patent/PL377696A1/pl not_active Application Discontinuation
- 2003-12-15 BR BR0317348-8A patent/BR0317348A/pt not_active IP Right Cessation
- 2003-12-15 EP EP03789278A patent/EP1575933A1/en not_active Withdrawn
- 2003-12-15 CA CA002507629A patent/CA2507629A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200418825A (en) | 2004-10-01 |
| EP1575933A1 (en) | 2005-09-21 |
| JP2006513181A (ja) | 2006-04-20 |
| CL2003002611A1 (es) | 2005-01-14 |
| PE20040913A1 (es) | 2005-01-18 |
| AU2003293882A1 (en) | 2004-07-09 |
| KR100781929B1 (ko) | 2007-12-04 |
| KR20050089157A (ko) | 2005-09-07 |
| US7098241B2 (en) | 2006-08-29 |
| CN100391954C (zh) | 2008-06-04 |
| GT200300285A (es) | 2004-07-14 |
| CA2507629A1 (en) | 2004-07-01 |
| BR0317348A (pt) | 2005-11-16 |
| PA8592101A1 (es) | 2004-11-02 |
| RU2348625C2 (ru) | 2009-03-10 |
| US20040122079A1 (en) | 2004-06-24 |
| UY28127A1 (es) | 2004-06-30 |
| CN1726204A (zh) | 2006-01-25 |
| RU2005122447A (ru) | 2006-05-27 |
| WO2004054999A1 (en) | 2004-07-01 |
| AR042459A1 (es) | 2005-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL164002A0 (en) | Sulfonyl-derivatives as novel inhibitors of histone deacetylase | |
| IL164003A0 (en) | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase | |
| IL164659A0 (en) | Inhibitors of histone deacetylase | |
| PL378181A1 (pl) | Pochodne kwasu hydroksamidowego jako inhibitory deacetylazy histonowej (HDAC) | |
| EG25655A (en) | Benzamide derivatives useful as histone deacetylase inhibitors | |
| AU2003215112A8 (en) | Novel bicyclic hydroxamates as inhibitors of histone deacetylase | |
| IL159097A0 (en) | Aromatic hydroxamic acid derivatives useful as hdac inhibitors | |
| AU2003219595A8 (en) | Alpha,beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors | |
| PL374970A1 (pl) | Podstawione kwasy tienylo-hydroksamowe jako inhibitory deacetylazy histonowej | |
| EP1735319A4 (en) | Histone deacetylase INHIBITORS | |
| EP1755601A4 (en) | HISTONE DEACETYLASE INHIBITORS | |
| AU2003303128A8 (en) | Inhibitors and methods of use thereof | |
| EP1567142A4 (en) | TREATMENT OF PULMONARY CELLS WITH HISTONE DEACETYLASE INHIBITORS | |
| EP1677731A4 (en) | THIOPHENE AND BENZOTHIOPHENE DERIVATIVES OF HYDROXAMIC ACID | |
| EP1496896A4 (en) | AKT INHIBITORS EFFECT | |
| EP1496906A4 (en) | HEMMER OF ACT ACTIVITY | |
| IL165910A0 (en) | Compositions of hyaluronic acid and methods of use | |
| AU2003286249A8 (en) | Histone deacetylase inhibitors | |
| EP1771167A4 (en) | Histone deacetylase INHIBITORS: | |
| PL371217A1 (pl) | Inhibitory integryny alfaVbeta6 | |
| EP1503749A4 (en) | METHIONINE INHIBITORS AMINOPEPTIDASE-2 AND METHODS OF USE THEREOF | |
| IL164267A0 (en) | Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase | |
| AU2003277878A1 (en) | Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors | |
| SG107315A1 (en) | Use of conjugated linoleic acid derivatives | |
| GB0418435D0 (en) | HDAC inhibitors and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |